Morgan Stanley’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-179
| Closed | -$2.48K | – | 8247 |
|
|
2025
Q1 | $2.48K | Buy |
179
+168
| +1,527% | +$2.32K | ﹤0.01% | 7134 |
|
|
2024
Q4 | $1.02K | Hold |
11
| – | – | ﹤0.01% | 7271 |
|
|
2024
Q3 | $5.71K | Hold |
11
| – | – | ﹤0.01% | 6874 |
|
|
2024
Q2 | $10.1K | Buy |
+11
| New | +$10.1K | ﹤0.01% | 6679 |
|
|
2023
Q1 | – | Hold |
0
| – | -$784 | – | 7813 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7505 |
|